Feedback / Questions
AZD1656 - Conduit Pharmaceuticals
https://www.globenewswire.com/news-release/2025/03/31/3052279/0/en/Conduit-Pharmaceuticals-Receives-U-S-Patent-Approval-For-Its-Lead-Asset-Targeting-Autoimmune-Diseases.html
Mar 31, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next